Cargando…

Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis

Previous studies have suggested that β-adrenergic signaling may regulate the growth of various cancers. The aim of our study is to investigate the association between the incidental use of beta-blockers for various conditions on the overall survival of patients with pancreatic ductal adenocarcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Anthony, Zylberberg, Haley M., Rustgi, Sheila D., Amin, Sunil P., Bar-Mashiah, Ariel, Boffetta, Paolo, Lucas, Aimee L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807087/
https://www.ncbi.nlm.nih.gov/pubmed/33441781
http://dx.doi.org/10.1038/s41598-020-79999-0